← Back to opportunities

PROVISIONS OF PCR MASTER MIXES – CLONALITY TESTING

Cardiff and Vale University Health Board

Buyer Contact Info

Buyer Name: Cardiff and Vale University Health Board

Buyer Address: Woodland House, Maes y Coed Road, Cardiff, UKL22, CF14 4HH, United Kingdom

Contact Name: Nicola Williams

Contact Email: Nicola.williams33@wales.nhs.com

Buyer Name: NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)

Buyer Address: 4-5 Charnwood Court Heol Billingsley, Cardiff, UKL15, CF15 7QZ, United Kingdom

Contact Email: Corporate.Services2@wales.nhs.uk

Status
complete
Procedure
direct
Value
355550.0 EUR
Published
02 Dec 2025, 13:45
Deadline
n/a
Contract Start
01 Jan 2026, 00:00
Contract End
31 Dec 2026, 23:59
Category
n/a
CPV
33696500 - Laboratory reagents
Region
n/a
Awarded To
Invivoscribe Technologies SARL
Official Source
Open Find a Tender

Description

The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales.

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot 1 Status: complete

Documents

Document Description: Not published

Awards

Award Title: PROVISIONS OF PCR MASTER MIXES – CLONALITY TESTING

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2026-12-31T23:59:59+00:00",
        "startDate": "2026-01-01T00:00:00+00:00"
      },
      "documents": [
        {
          "datePublished": "2025-12-02T13:45:33Z",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "078933-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/078933-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Laboratory reagents",
              "id": "33696500",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UKL22"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-12-15T23:59:59+00:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-PPON-PXNH-7642-BTWQ",
          "name": "Invivoscribe Technologies SARL"
        }
      ],
      "title": "PROVISIONS OF PCR MASTER MIXES \u2013 CLONALITY TESTING",
      "value": {
        "amount": 355550.0,
        "amountGross": 426659.98,
        "currency": "EUR"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PPPR-7969-BTJG",
    "name": "Cardiff and Vale University Health Board"
  },
  "date": "2025-12-02T13:45:33Z",
  "id": "078933-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05ecf5",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cardiff",
        "postalCode": "CF14 4HH",
        "region": "UKL22",
        "streetAddress": "Woodland House, Maes y Coed Road"
      },
      "contactPoint": {
        "email": "Nicola.williams33@wales.nhs.com",
        "name": "Nicola Williams"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          },
          {
            "description": "Welsh devolved regulations apply",
            "id": "GB-WLS",
            "scheme": "UK_CA_DEVOLVED_REGULATIONS"
          }
        ],
        "url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
      },
      "id": "GB-PPON-PPPR-7969-BTJG",
      "identifier": {
        "id": "PPPR-7969-BTJG",
        "scheme": "GB-PPON"
      },
      "name": "Cardiff and Vale University Health Board",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cardiff",
        "postalCode": "CF15 7QZ",
        "region": "UKL15",
        "streetAddress": "4-5 Charnwood Court Heol Billingsley"
      },
      "contactPoint": {
        "email": "Corporate.Services2@wales.nhs.uk"
      },
      "id": "GB-PPON-PXWV-6492-CGMN",
      "identifier": {
        "id": "PXWV-6492-CGMN",
        "scheme": "GB-PPON"
      },
      "name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
      "roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP\u2019s operations, but NWSSP itself serves all NHS organisations across Wales.",
      "roles": [
        "procuringEntity"
      ]
    },
    {
      "address": {
        "country": "DE",
        "countryName": "Germany",
        "locality": "Hallbergmoos",
        "postalCode": "85399",
        "region": "DE",
        "streetAddress": "Zeppelinstra\u00dfe 1"
      },
      "contactPoint": {
        "email": "kkampe@invivoscribe.com"
      },
      "details": {
        "scale": "large",
        "url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
        "vcse": false
      },
      "id": "GB-PPON-PXNH-7642-BTWQ",
      "identifier": {
        "id": "PXNH-7642-BTWQ",
        "scheme": "GB-PPON"
      },
      "name": "Invivoscribe Technologies SARL",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "CAV-DIR (25-26) 99",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "The All Wales Medical Genomics Service (AWMGS) requires PCR mastermixes and associated reagents for B and T cell clonality testing, which are critical for diagnosing and monitoring haematological malignancies such as lymphoma. These assays must include validated clonal and polyclonal controls and a control gene to ensure accurate and reproducible results. Changing supplier would necessitate full revalidation and re-accreditation of all existing assays under UKAS ISO 15189:2022 standards\u2014a process that is highly complex, resource-intensive, and time-consuming. This would cause significant disruption to diagnostic services, resulting in delays to patient testing and reporting. Such delays pose a serious risk to patient safety, as timely diagnosis is essential for initiating treatment and improving clinical outcomes. Any interruption could lead to missed or late diagnoses, directly endangering patient health and potentially impacting survival rates. To avoid these unacceptable risks and maintain continuity of service, a direct award is the only viable option, service resilience, and safeguarding patient care across Wales.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "riskDetails": "The main risks to contract performance include supply chain disruption, single supplier dependency, and potential delays in delivery or technical support. These risks could impact continuity of testing and patient care. Mitigation measures include strict service level agreements, proactive communication requirements, and performance monitoring through AWMGS\u2019s Quality Management System.",
    "status": "complete",
    "title": "PROVISIONS OF PCR MASTER MIXES \u2013 CLONALITY TESTING"
  }
}